In this study, we demonstrate that patients with cirrhosis express significantly higher levels of FGL2 compared with patients without cirrhosis, independently of whether they have HCC, suggesting that the presence of activated HSCs may account for the high levels of FGL2. Here, FGL2 is linked to hepatocellular carcinoma.